CC
LMAT icon

Centiva Capital’s LeMaitre Vascular LMAT Stock Holding History

Centiva Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,062
Closed -$225K – 2061
2026
Q1 		$225K Buy
+2,062
New +$197K ﹤0.01% 1220
2025
Q3 		– Sell
-3,064
Closed -$254K – 1512
2025
Q2 		$254K Sell
3,064
-3,929
-56% -$328K ﹤0.01% 1243
2025
Q1 		$587K Buy
6,993
+3,948
+130% +$367K 0.02% 732
2024
Q4 		$281K Buy
+3,045
New +$293K 0.01% 1178
2024
Q3 		– Sell
-7,326
Closed -$603K – 2399
2024
Q2 		$603K Buy
7,326
+3,267
+80% +$240K 0.01% 1034
2024
Q1 		$269K Buy
+4,059
New +$250K 0.01% 1303

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Centiva Capital's LMAT Position: Q2 2026 in Review

Centiva Capital sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 2,062 shares — an estimated $225K sold.

Centiva Capital first reported a position in LMAT in Q1 2024 and held it in 6 quarters. The position peaked at $603K in Q2 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Centiva Capital reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 2,062 LeMaitre Vascular shares in Q2 2026, an estimated $225K.
  • Centiva Capital first reported a position in LeMaitre Vascular in Q1 2024 and held it in 6 quarters.
  • Centiva Capital's LeMaitre Vascular position peaked at $603K in Q2 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.